Akhu Therapeutics has licensed a UA technology that is targeted to allow doctors to relieve the symptoms of acute depression in a fraction of the time required for current therapies.

TLA is working with College of Medicine researchers on bringing a new snakebite treatment to market that may serve as a “bridge” to buy time until medical care is available.

In 2015 the College of Agriculture and Life Sciences tripled the number of executed license and option agreements, launched three start-up companies, and had a record year in IP income.

TLA recently earned a designation as an I-Corps Site. Now, teams need help defining and protecting their intellectual property. The UA College of Law IP Clinic is stepping up to help.

Startup company Yumanity Therapeutics has licensed a UA-invented prodrug and its analogues to develop treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s and ALS that affect over 55 million people.

It takes years of experience to gain the know-how to successfully get a high-tech company off the ground. With its Mentors-in-Residence program, TLA is bringing in proven experts to help start the newest high-tech UA startups on the path to success.